HomeComparePVNC vs MRK

PVNC vs MRK: Dividend Comparison 2026

PVNC yields 57.14% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PVNC wins by $509.0K in total portfolio value
10 years
PVNC
PVNC
● Live price
57.14%
Share price
$3.50
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$565.8K
Annual income
$127,359.58
Full PVNC calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — PVNC vs MRK

📍 PVNC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPVNCMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PVNC + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PVNC pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PVNC
Annual income on $10K today (after 15% tax)
$4,857.14/yr
After 10yr DRIP, annual income (after tax)
$108,255.64/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, PVNC beats the other by $99,927.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PVNC + MRK for your $10,000?

PVNC: 50%MRK: 50%
100% MRK50/50100% PVNC
Portfolio after 10yr
$311.3K
Annual income
$68,578.86/yr
Blended yield
22.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PVNC
No analyst data
Altman Z
-97.6
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PVNC buys
0
MRK buys
0
No recent congressional trades found for PVNC or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPVNCMRK
Forward yield57.14%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$565.8K$56.8K
Annual income after 10y$127,359.58$9,798.13
Total dividends collected$464.7K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PVNC vs MRK ($10,000, DRIP)

YearPVNC PortfolioPVNC Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$16,414$5,714.29$11,206$366.19+$5.2KPVNC
2$26,329$8,765.97$12,650$502.35+$13.7KPVNC
3$41,313$13,141.14$14,407$694.19+$26.9KPVNC
4$63,476$19,270.90$16,585$967.82+$46.9KPVNC
5$95,591$27,671.86$19,342$1,363.89+$76.2KPVNC
6$141,229$38,945.95$22,913$1,947.19+$118.3KPVNC
7$204,890$53,775.28$27,662$2,823.89+$177.2KPVNC
8$292,144$72,911.59$34,159$4,173.35+$258.0KPVNC
9$409,754$97,160.29$43,337$6,308.80+$366.4KPVNC
10$565,797$127,359.58$56,776$9,798.13+$509.0KPVNC

PVNC vs MRK: Complete Analysis 2026

PVNCStock

Prevention Insurance.Com does not have significant operations. The company intends to pursue a business combination through acquisition or merger with an existing company. Previously, it was involved in health and life insurance agency business. The company was formerly known as Vita Plus Industries, Inc. and changed its name to Prevention Insurance.Com in March 1999. Prevention Insurance.Com was incorporated in 1975 and is based in Melbourne, Australia. Prevention Insurance.Com is a subsidiary of Copper Hill Assets Inc.

Full PVNC Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PVNC vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PVNC vs SCHDPVNC vs JEPIPVNC vs OPVNC vs KOPVNC vs MAINPVNC vs JNJPVNC vs ABBVPVNC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.